BE study involving injectable device [Design Issues]

posted by Ohlbe – France, 2014-08-25 01:40 (4325 d 09:59 ago) – Posting: # 13424
Views: 6,447

Dear Dan and John,

❝ The aim of a BE study is to show differences in formulations. As long as there is no difference in the way of administration or in technical performance.


True. But if the administration device differs between the two products and there is a technical difficulty in administering one of them, this may result in a different bioavailability if patients don't do the administration properly. In this regard I think it makes sense to ask the subjects to self-administer the products.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
365 visitors (0 registered, 365 guests [including 23 identified bots]).
Forum time: 11:39 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5